- Home
- BKU vs RCKT Comparison
BKU vs RCKT Comparison
Compare BKU & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKU | RCKT |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 394.2M |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BKU | RCKT |
|---|---|---|
| Price | $43.88 | $2.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $51.58 | $29.73 |
| AVG Volume (30 Days) | 810.3K | ★ 1.7M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | 14.61 | ★ 26.37 |
| EPS | ★ 1.79 | 0.66 |
| Revenue | ★ $21,732,000.00 | N/A |
| Revenue This Year | $16.26 | N/A |
| Revenue Next Year | $4.78 | $64.28 |
| P/E Ratio | $24.24 | ★ $4.08 |
| Revenue Growth | ★ 7.45 | N/A |
| 52 Week Low | $35.10 | $2.53 |
| 52 Week High | $52.11 | $5.45 |
Technical Indicators
Market Signals| Indicator | BKU | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 37.04 | 27.59 |
| Support Level | $41.95 | N/A |
| Resistance Level | $48.20 | $3.67 |
| Average True Range (ATR) | 0.91 | 0.23 |
| MACD | -0.09 | -0.10 |
| Stochastic Oscillator | 22.45 | 3.71 |
Price Performance
Historical ComparisonAbout BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses. The company also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products including commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.